Interstitial lung abnormality evaluated by an automated quantification system: prevalence and progression rate
Background Despite the importance of recognizing interstitial lung abnormalities, screening methods using computer-based quantitative analysis are not well developed, and studies on the subject with an Asian population are rare. We aimed to identify the prevalence and progression rate of interstitia...
Saved in:
| Published in | Respiratory research Vol. 25; no. 1; pp. 78 - 10 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
06.02.2024
BioMed Central Ltd Nature Publishing Group BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1465-993X 1465-9921 1465-993X |
| DOI | 10.1186/s12931-024-02715-3 |
Cover
| Abstract | Background
Despite the importance of recognizing interstitial lung abnormalities, screening methods using computer-based quantitative analysis are not well developed, and studies on the subject with an Asian population are rare. We aimed to identify the prevalence and progression rate of interstitial lung abnormality evaluated by an automated quantification system in the Korean population.
Methods
A total of 2,890 healthy participants in a health screening program (mean age: 49 years, men: 79.5%) with serial chest computed tomography images obtained at least 5 years apart were included. Quantitative lung fibrosis scores were measured on the chest images by an automated quantification system. Interstitial lung abnormalities were defined as a score ≥ 3, and progression as any score increased above baseline.
Results
Interstitial lung abnormalities were identified in 251 participants (8.6%), who were older and had a higher body mass index. The prevalence increased with age. Quantification of the follow-up images (median interval: 6.5 years) showed that 23.5% (59/251) of participants initially diagnosed with interstitial lung abnormality exhibited progression, and 11% had developed abnormalities (290/2639). Older age, higher body mass index, and higher erythrocyte sedimentation rate were independent risk factors for progression or development. The interstitial lung abnormality group had worse survival on follow-up (5-year mortality: 3.4% vs. 1.5%;
P
= 0.010).
Conclusions
Interstitial lung abnormality could be identified in one-tenth of the participants, and a quarter of them showed progression. Older age, higher body mass index and higher erythrocyte sedimentation rate increased the risk of development or progression of interstitial lung abnormality. |
|---|---|
| AbstractList | Despite the importance of recognizing interstitial lung abnormalities, screening methods using computer-based quantitative analysis are not well developed, and studies on the subject with an Asian population are rare. We aimed to identify the prevalence and progression rate of interstitial lung abnormality evaluated by an automated quantification system in the Korean population.BACKGROUNDDespite the importance of recognizing interstitial lung abnormalities, screening methods using computer-based quantitative analysis are not well developed, and studies on the subject with an Asian population are rare. We aimed to identify the prevalence and progression rate of interstitial lung abnormality evaluated by an automated quantification system in the Korean population.A total of 2,890 healthy participants in a health screening program (mean age: 49 years, men: 79.5%) with serial chest computed tomography images obtained at least 5 years apart were included. Quantitative lung fibrosis scores were measured on the chest images by an automated quantification system. Interstitial lung abnormalities were defined as a score ≥ 3, and progression as any score increased above baseline.METHODSA total of 2,890 healthy participants in a health screening program (mean age: 49 years, men: 79.5%) with serial chest computed tomography images obtained at least 5 years apart were included. Quantitative lung fibrosis scores were measured on the chest images by an automated quantification system. Interstitial lung abnormalities were defined as a score ≥ 3, and progression as any score increased above baseline.Interstitial lung abnormalities were identified in 251 participants (8.6%), who were older and had a higher body mass index. The prevalence increased with age. Quantification of the follow-up images (median interval: 6.5 years) showed that 23.5% (59/251) of participants initially diagnosed with interstitial lung abnormality exhibited progression, and 11% had developed abnormalities (290/2639). Older age, higher body mass index, and higher erythrocyte sedimentation rate were independent risk factors for progression or development. The interstitial lung abnormality group had worse survival on follow-up (5-year mortality: 3.4% vs. 1.5%; P = 0.010).RESULTSInterstitial lung abnormalities were identified in 251 participants (8.6%), who were older and had a higher body mass index. The prevalence increased with age. Quantification of the follow-up images (median interval: 6.5 years) showed that 23.5% (59/251) of participants initially diagnosed with interstitial lung abnormality exhibited progression, and 11% had developed abnormalities (290/2639). Older age, higher body mass index, and higher erythrocyte sedimentation rate were independent risk factors for progression or development. The interstitial lung abnormality group had worse survival on follow-up (5-year mortality: 3.4% vs. 1.5%; P = 0.010).Interstitial lung abnormality could be identified in one-tenth of the participants, and a quarter of them showed progression. Older age, higher body mass index and higher erythrocyte sedimentation rate increased the risk of development or progression of interstitial lung abnormality.CONCLUSIONSInterstitial lung abnormality could be identified in one-tenth of the participants, and a quarter of them showed progression. Older age, higher body mass index and higher erythrocyte sedimentation rate increased the risk of development or progression of interstitial lung abnormality. BackgroundDespite the importance of recognizing interstitial lung abnormalities, screening methods using computer-based quantitative analysis are not well developed, and studies on the subject with an Asian population are rare. We aimed to identify the prevalence and progression rate of interstitial lung abnormality evaluated by an automated quantification system in the Korean population.MethodsA total of 2,890 healthy participants in a health screening program (mean age: 49 years, men: 79.5%) with serial chest computed tomography images obtained at least 5 years apart were included. Quantitative lung fibrosis scores were measured on the chest images by an automated quantification system. Interstitial lung abnormalities were defined as a score ≥ 3, and progression as any score increased above baseline.ResultsInterstitial lung abnormalities were identified in 251 participants (8.6%), who were older and had a higher body mass index. The prevalence increased with age. Quantification of the follow-up images (median interval: 6.5 years) showed that 23.5% (59/251) of participants initially diagnosed with interstitial lung abnormality exhibited progression, and 11% had developed abnormalities (290/2639). Older age, higher body mass index, and higher erythrocyte sedimentation rate were independent risk factors for progression or development. The interstitial lung abnormality group had worse survival on follow-up (5-year mortality: 3.4% vs. 1.5%; P = 0.010).ConclusionsInterstitial lung abnormality could be identified in one-tenth of the participants, and a quarter of them showed progression. Older age, higher body mass index and higher erythrocyte sedimentation rate increased the risk of development or progression of interstitial lung abnormality. Abstract Background Despite the importance of recognizing interstitial lung abnormalities, screening methods using computer-based quantitative analysis are not well developed, and studies on the subject with an Asian population are rare. We aimed to identify the prevalence and progression rate of interstitial lung abnormality evaluated by an automated quantification system in the Korean population. Methods A total of 2,890 healthy participants in a health screening program (mean age: 49 years, men: 79.5%) with serial chest computed tomography images obtained at least 5 years apart were included. Quantitative lung fibrosis scores were measured on the chest images by an automated quantification system. Interstitial lung abnormalities were defined as a score ≥ 3, and progression as any score increased above baseline. Results Interstitial lung abnormalities were identified in 251 participants (8.6%), who were older and had a higher body mass index. The prevalence increased with age. Quantification of the follow-up images (median interval: 6.5 years) showed that 23.5% (59/251) of participants initially diagnosed with interstitial lung abnormality exhibited progression, and 11% had developed abnormalities (290/2639). Older age, higher body mass index, and higher erythrocyte sedimentation rate were independent risk factors for progression or development. The interstitial lung abnormality group had worse survival on follow-up (5-year mortality: 3.4% vs. 1.5%; P = 0.010). Conclusions Interstitial lung abnormality could be identified in one-tenth of the participants, and a quarter of them showed progression. Older age, higher body mass index and higher erythrocyte sedimentation rate increased the risk of development or progression of interstitial lung abnormality. Despite the importance of recognizing interstitial lung abnormalities, screening methods using computer-based quantitative analysis are not well developed, and studies on the subject with an Asian population are rare. We aimed to identify the prevalence and progression rate of interstitial lung abnormality evaluated by an automated quantification system in the Korean population. A total of 2,890 healthy participants in a health screening program (mean age: 49 years, men: 79.5%) with serial chest computed tomography images obtained at least 5 years apart were included. Quantitative lung fibrosis scores were measured on the chest images by an automated quantification system. Interstitial lung abnormalities were defined as a score ≥ 3, and progression as any score increased above baseline. Interstitial lung abnormalities were identified in 251 participants (8.6%), who were older and had a higher body mass index. The prevalence increased with age. Quantification of the follow-up images (median interval: 6.5 years) showed that 23.5% (59/251) of participants initially diagnosed with interstitial lung abnormality exhibited progression, and 11% had developed abnormalities (290/2639). Older age, higher body mass index, and higher erythrocyte sedimentation rate were independent risk factors for progression or development. The interstitial lung abnormality group had worse survival on follow-up (5-year mortality: 3.4% vs. 1.5%; P = 0.010). Interstitial lung abnormality could be identified in one-tenth of the participants, and a quarter of them showed progression. Older age, higher body mass index and higher erythrocyte sedimentation rate increased the risk of development or progression of interstitial lung abnormality. Background Despite the importance of recognizing interstitial lung abnormalities, screening methods using computer-based quantitative analysis are not well developed, and studies on the subject with an Asian population are rare. We aimed to identify the prevalence and progression rate of interstitial lung abnormality evaluated by an automated quantification system in the Korean population. Methods A total of 2,890 healthy participants in a health screening program (mean age: 49 years, men: 79.5%) with serial chest computed tomography images obtained at least 5 years apart were included. Quantitative lung fibrosis scores were measured on the chest images by an automated quantification system. Interstitial lung abnormalities were defined as a score ≥ 3, and progression as any score increased above baseline. Results Interstitial lung abnormalities were identified in 251 participants (8.6%), who were older and had a higher body mass index. The prevalence increased with age. Quantification of the follow-up images (median interval: 6.5 years) showed that 23.5% (59/251) of participants initially diagnosed with interstitial lung abnormality exhibited progression, and 11% had developed abnormalities (290/2639). Older age, higher body mass index, and higher erythrocyte sedimentation rate were independent risk factors for progression or development. The interstitial lung abnormality group had worse survival on follow-up (5-year mortality: 3.4% vs. 1.5%; P = 0.010). Conclusions Interstitial lung abnormality could be identified in one-tenth of the participants, and a quarter of them showed progression. Older age, higher body mass index and higher erythrocyte sedimentation rate increased the risk of development or progression of interstitial lung abnormality. Background Despite the importance of recognizing interstitial lung abnormalities, screening methods using computer-based quantitative analysis are not well developed, and studies on the subject with an Asian population are rare. We aimed to identify the prevalence and progression rate of interstitial lung abnormality evaluated by an automated quantification system in the Korean population. Methods A total of 2,890 healthy participants in a health screening program (mean age: 49 years, men: 79.5%) with serial chest computed tomography images obtained at least 5 years apart were included. Quantitative lung fibrosis scores were measured on the chest images by an automated quantification system. Interstitial lung abnormalities were defined as a score [greater than or equal to] 3, and progression as any score increased above baseline. Results Interstitial lung abnormalities were identified in 251 participants (8.6%), who were older and had a higher body mass index. The prevalence increased with age. Quantification of the follow-up images (median interval: 6.5 years) showed that 23.5% (59/251) of participants initially diagnosed with interstitial lung abnormality exhibited progression, and 11% had developed abnormalities (290/2639). Older age, higher body mass index, and higher erythrocyte sedimentation rate were independent risk factors for progression or development. The interstitial lung abnormality group had worse survival on follow-up (5-year mortality: 3.4% vs. 1.5%; P = 0.010). Conclusions Interstitial lung abnormality could be identified in one-tenth of the participants, and a quarter of them showed progression. Older age, higher body mass index and higher erythrocyte sedimentation rate increased the risk of development or progression of interstitial lung abnormality. Keywords: Interstitial lung disease, Fibrosis, Prevalence, Prognosis, Mortality Despite the importance of recognizing interstitial lung abnormalities, screening methods using computer-based quantitative analysis are not well developed, and studies on the subject with an Asian population are rare. We aimed to identify the prevalence and progression rate of interstitial lung abnormality evaluated by an automated quantification system in the Korean population. A total of 2,890 healthy participants in a health screening program (mean age: 49 years, men: 79.5%) with serial chest computed tomography images obtained at least 5 years apart were included. Quantitative lung fibrosis scores were measured on the chest images by an automated quantification system. Interstitial lung abnormalities were defined as a score [greater than or equal to] 3, and progression as any score increased above baseline. Interstitial lung abnormalities were identified in 251 participants (8.6%), who were older and had a higher body mass index. The prevalence increased with age. Quantification of the follow-up images (median interval: 6.5 years) showed that 23.5% (59/251) of participants initially diagnosed with interstitial lung abnormality exhibited progression, and 11% had developed abnormalities (290/2639). Older age, higher body mass index, and higher erythrocyte sedimentation rate were independent risk factors for progression or development. The interstitial lung abnormality group had worse survival on follow-up (5-year mortality: 3.4% vs. 1.5%; P = 0.010). Interstitial lung abnormality could be identified in one-tenth of the participants, and a quarter of them showed progression. Older age, higher body mass index and higher erythrocyte sedimentation rate increased the risk of development or progression of interstitial lung abnormality. |
| ArticleNumber | 78 |
| Audience | Academic |
| Author | Oh, Ju Hyun Song, Jin Woo Kim, Grace Hyun J. |
| Author_xml | – sequence: 1 givenname: Ju Hyun surname: Oh fullname: Oh, Ju Hyun organization: Department of Pulmonology and Critical Care Medicine, Sanggye Paik Hospital, Inje University College of Medicine – sequence: 2 givenname: Grace Hyun J. surname: Kim fullname: Kim, Grace Hyun J. organization: Department of Radiological Sciences, David Geffen School of Medicine at UCLA – sequence: 3 givenname: Jin Woo surname: Song fullname: Song, Jin Woo email: jwsongasan@gmail.com organization: Department of Pulmonology and Critical Care Medicine, Asan Medical Centre, University of Ulsan College of Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38321467$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNUstq3DAUNSWlebQ_0EUxdNONU0uyLambEkIfA4FuWuhOyPK1q2BLE0lOmL_vnUfTmVCGYoT1OOfo6px7np047yDLXpPykhDRvI-ESkaKklY4OKkL9iw7I1VTF1Kynyd789PsPMbbsiRc8PpFdsoEo3jIzzK3cAlCTDZZPebj7IZct86HSY82rXK41-OsE3R5u8q1y_Wc_LRZ383aJdtbo5P1Lo-rmGD6kC_DmgLOAMI7XPohQIxrSEDey-x5r8cIr3b_i-zH50_fr78WN9--LK6vbgrTsCYVuqfAOdGlpEA4Y7wEwfqW1VByyRtRdoyZupe16WnVSmIobWlZ9rxpa3xzwy6yxVa38_pWLYOddFgpr63abPgwKB2SNSMo6FvZM2k6Q0zFRSNJLQwILiQhWnSAWmyrNbulXj3ocXwUJKVaJ6G2SShMQm2SUAxZH7es5dxO0BlwKejxoJTDE2d_qcHfo6aoRCVLVHi3Uwj-boaY1GSjgXHUDvwcFZWUMVqLZn3Z2yfQWz8Hhw4rRKClDEs7hkKtuuGkIntaA-aorOs9lmfWV6srLiiREpNB1OU_UPh1MFmDfdpb3D8gvNn349GIP62IALEFmOBjDNArY9OmuVDZjse9pk-o_xXQLtaIYDdA-OvGEdZvOpMRgg |
| CitedBy_id | crossref_primary_10_1186_s12880_025_01561_z crossref_primary_10_1111_resp_70026 crossref_primary_10_3904_kjim_2024_335 |
| Cites_doi | 10.1183/09031936.05.00034805 10.1148/radiol.12112516 10.1210/jc.2004-1696 10.1183/13993003.00129-2016 10.1016/j.chest.2020.08.017 10.1371/journal.pmed.0050093 10.1136/thoraxjnl-2018-212430 10.1148/radiol.221172 10.1183/13993003.04053-2020 10.1164/rccm.201809-1652OC 10.1016/j.ejro.2020.100228 10.1016/j.pupt.2017.02.005 10.1183/23120541.00074-2016 10.1016/j.rmed.2010.05.014 10.1016/j.chest.2021.03.058 10.1164/rccm.201909-1834OC 10.1016/j.acra.2009.07.016 10.1183/16000617.0022-2019 10.1148/radiol.2282011860 10.1164/rccm.202110-2412OC 10.1136/thoraxjnl-2016-209568 10.1109/TMI.2015.2459064 10.1172/JCI200319246 10.1001/jama.2016.0518 10.1183/13993003.00559-2017 10.1177/0962280214537390 10.1164/rccm.201109-1618OC 10.1007/978-3-030-00946-5_21 10.1016/j.cyto.2017.08.019 10.1016/j.rmed.2018.02.001 10.1164/rccm.201512-2523OC 10.1016/j.acra.2016.08.023 10.1164/ajrccm.165.3.2107134 10.1136/thoraxjnl-2018-212446 10.1186/s12890-015-0124-x 10.1183/13993003.01950-2022 10.1164/rccm.201709-1845OC 10.1148/radiol.222828 10.1016/S2213-2600(20)30168-5 10.1148/radiol.13120816 10.1111/resp.13820 10.1183/23120541.00115-2019 10.1007/s00330-011-2223-2 10.1056/NEJMoa1216076 10.21037/jtd.2017.08.17 10.1111/imj.14148 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2024 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7U7 7U9 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P M7N PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM ADTOC UNPAY DOA |
| DOI | 10.1186/s12931-024-02715-3 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall Directory of Open Access Journals (DOAJ) (NIESG) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Environmental Sciences and Pollution Management ProQuest Central ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts Toxicology Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) ProQuest Central China MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database Publicly Available Content Database MEDLINE |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals (WRLC) url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 6 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1465-993X |
| EndPage | 10 |
| ExternalDocumentID | oai_doaj_org_article_efb9f39cdc1c47869158ce878911a8de 10.1186/s12931-024-02715-3 PMC10848490 A782199771 38321467 10_1186_s12931_024_02715_3 |
| Genre | Journal Article |
| GeographicLocations | South Korea |
| GeographicLocations_xml | – name: South Korea |
| GrantInformation_xml | – fundername: National Research Foundation of Korea grantid: NRF-2022R1A2B5B02001602 funderid: http://dx.doi.org/10.13039/501100003725 – fundername: Korea National Institute of Health grantid: 2021ER120701 funderid: http://dx.doi.org/10.13039/501100003653 – fundername: Korea Environmental Industry and Technology Institute grantid: ARQ202201450001 funderid: http://dx.doi.org/10.13039/501100003654 – fundername: Korea Environmental Industry and Technology Institute grantid: ARQ202201450001 – fundername: National Research Foundation of Korea grantid: NRF-2022R1A2B5B02001602 – fundername: Korea National Institute of Health grantid: 2021ER120701 |
| GroupedDBID | --- 0R~ 29P 2WC 4.4 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX CITATION ALIPV CGR CUY CVF ECM EIF NPM 3V. 7QL 7U7 7U9 7XB 8FK AZQEC C1K DWQXO H94 K9. M7N PKEHL PQEST PQUKI PRINS 7X8 5PM 2VQ ADTOC AHSBF EJD H13 IPNFZ RIG UNPAY |
| ID | FETCH-LOGICAL-c636t-af2e771a092e173370e83fb35e0797680d33c5f95cf24b91c22b200f76b546563 |
| IEDL.DBID | M48 |
| ISSN | 1465-993X 1465-9921 |
| IngestDate | Tue Oct 14 19:09:19 EDT 2025 Sun Oct 26 01:35:43 EDT 2025 Tue Sep 30 17:10:15 EDT 2025 Tue Oct 14 01:22:21 EDT 2025 Tue Oct 07 05:22:03 EDT 2025 Mon Oct 06 18:31:10 EDT 2025 Mon Oct 20 22:59:37 EDT 2025 Mon Oct 20 17:03:57 EDT 2025 Mon Jul 21 06:00:33 EDT 2025 Wed Oct 01 03:23:45 EDT 2025 Thu Apr 24 23:00:15 EDT 2025 Sat Sep 06 07:29:00 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Prevalence Prognosis Interstitial lung disease Mortality Fibrosis |
| Language | English |
| License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. cc-by |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c636t-af2e771a092e173370e83fb35e0797680d33c5f95cf24b91c22b200f76b546563 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12931-024-02715-3 |
| PMID | 38321467 |
| PQID | 2925671413 |
| PQPubID | 42864 |
| PageCount | 10 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_efb9f39cdc1c47869158ce878911a8de unpaywall_primary_10_1186_s12931_024_02715_3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10848490 proquest_miscellaneous_2923325863 proquest_journals_3256363024 proquest_journals_2925671413 gale_infotracmisc_A782199771 gale_infotracacademiconefile_A782199771 pubmed_primary_38321467 crossref_citationtrail_10_1186_s12931_024_02715_3 crossref_primary_10_1186_s12931_024_02715_3 springer_journals_10_1186_s12931_024_02715_3 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-02-06 |
| PublicationDateYYYYMMDD | 2024-02-06 |
| PublicationDate_xml | – month: 02 year: 2024 text: 2024-02-06 day: 06 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Respiratory research |
| PublicationTitleAbbrev | Respir Res |
| PublicationTitleAlternate | Respir Res |
| PublicationYear | 2024 |
| Publisher | BioMed Central BioMed Central Ltd Nature Publishing Group BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Nature Publishing Group – name: BMC |
| References | IO Rosas (2715_CR41) 2008; 5 ML Salisbury (2715_CR8) 2020; 201 HJ Kim (2715_CR27) 2011; 21 GM Hunninghake (2715_CR7) 2019; 74 NA Obuchowski (2715_CR29) 2015; 24 AJ Podolanczuk (2715_CR17) 2016; 48 SY Ash (2715_CR16) 2017; 24 K Tsushima (2715_CR36) 2010; 104 T Watadani (2715_CR14) 2013; 266 GM Hunninghake (2715_CR32) 2013; 368 M Mascalchi (2715_CR21) 2017; 9 JA Mackintosh (2715_CR4) 2019; 49 M Aiello (2715_CR10) 2017; 44 2715_CR25 GR Washko (2715_CR30) 2010; 17 HL Kundel (2715_CR31) 2003; 228 2715_CR48 RK Putman (2715_CR6) 2019; 200 AJ Podolanczuk (2715_CR39) 2017; 72 2715_CR42 2715_CR40 2715_CR22 SA Papiris (2715_CR44) 2018; 102 CR Kliment (2715_CR19) 2015; 15 SP Weisberg (2715_CR45) 2003; 112 TS Lee (2715_CR3) 2021; 159 DY Chong (2715_CR24) 2016; 35 T Araki (2715_CR2) 2016; 194 N Hoyer (2715_CR5) 2018; 136 SK Mathai (2715_CR15) 2019; 74 J Widell (2715_CR13) 2020; 7 GY Jin (2715_CR20) 2013; 268 S Kafaja (2715_CR28) 2018; 197 RK Putman (2715_CR33) 2016; 315 KJ Chae (2715_CR34) 2023; 307 H Hatabu (2715_CR1) 2020; 8 2715_CR38 2715_CR37 MR Miller (2715_CR23) 2005; 26 TJ Doyle (2715_CR9) 2012; 185 JM Bruun (2715_CR46) 2005; 90 2715_CR18 HG Kim (2715_CR26) 2010; 28 MR Anderson (2715_CR43) 2021; 160 2715_CR12 JE Lee (2715_CR35) 2022; 306 H Ohnishi (2715_CR47) 2002; 165 2715_CR11 |
| References_xml | – volume: 26 start-page: 319 year: 2005 ident: 2715_CR23 publication-title: Eur Respir J doi: 10.1183/09031936.05.00034805 – volume: 266 start-page: 936 year: 2013 ident: 2715_CR14 publication-title: Radiology doi: 10.1148/radiol.12112516 – volume: 90 start-page: 2282 year: 2005 ident: 2715_CR46 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2004-1696 – volume: 48 start-page: 1442 year: 2016 ident: 2715_CR17 publication-title: Eur Respir J doi: 10.1183/13993003.00129-2016 – volume: 159 start-page: 128 year: 2021 ident: 2715_CR3 publication-title: Chest doi: 10.1016/j.chest.2020.08.017 – volume: 5 start-page: e93 year: 2008 ident: 2715_CR41 publication-title: PLoS Med doi: 10.1371/journal.pmed.0050093 – volume: 74 start-page: 1131 year: 2019 ident: 2715_CR15 publication-title: Thorax doi: 10.1136/thoraxjnl-2018-212430 – volume: 306 start-page: e221172 year: 2022 ident: 2715_CR35 publication-title: Radiology doi: 10.1148/radiol.221172 – ident: 2715_CR40 doi: 10.1183/13993003.04053-2020 – volume: 200 start-page: 175 year: 2019 ident: 2715_CR6 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201809-1652OC – volume: 7 start-page: 100228 year: 2020 ident: 2715_CR13 publication-title: Eur J Radiol Open doi: 10.1016/j.ejro.2020.100228 – volume: 44 start-page: 7 year: 2017 ident: 2715_CR10 publication-title: Pulm Pharmacol Ther doi: 10.1016/j.pupt.2017.02.005 – ident: 2715_CR42 doi: 10.1183/23120541.00074-2016 – volume: 104 start-page: 1712 year: 2010 ident: 2715_CR36 publication-title: Respir Med doi: 10.1016/j.rmed.2010.05.014 – volume: 160 start-page: 582 year: 2021 ident: 2715_CR43 publication-title: Chest doi: 10.1016/j.chest.2021.03.058 – ident: 2715_CR12 – volume: 201 start-page: 1230 year: 2020 ident: 2715_CR8 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201909-1834OC – volume: 17 start-page: 48 year: 2010 ident: 2715_CR30 publication-title: Acad Radiol doi: 10.1016/j.acra.2009.07.016 – ident: 2715_CR11 doi: 10.1183/16000617.0022-2019 – volume: 228 start-page: 303 year: 2003 ident: 2715_CR31 publication-title: Radiology doi: 10.1148/radiol.2282011860 – ident: 2715_CR37 doi: 10.1164/rccm.202110-2412OC – volume: 72 start-page: 472 year: 2017 ident: 2715_CR39 publication-title: Thorax doi: 10.1136/thoraxjnl-2016-209568 – volume: 35 start-page: 144 year: 2016 ident: 2715_CR24 publication-title: IEEE Trans Med Imaging doi: 10.1109/TMI.2015.2459064 – volume: 112 start-page: 1796 year: 2003 ident: 2715_CR45 publication-title: J Clin Invest doi: 10.1172/JCI200319246 – volume: 315 start-page: 672 year: 2016 ident: 2715_CR33 publication-title: JAMA doi: 10.1001/jama.2016.0518 – ident: 2715_CR38 doi: 10.1183/13993003.00559-2017 – volume: 24 start-page: 68 year: 2015 ident: 2715_CR29 publication-title: Stat Methods Med Res doi: 10.1177/0962280214537390 – volume: 185 start-page: 756 year: 2012 ident: 2715_CR9 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201109-1618OC – ident: 2715_CR25 doi: 10.1007/978-3-030-00946-5_21 – volume: 102 start-page: 168 year: 2018 ident: 2715_CR44 publication-title: Cytokine doi: 10.1016/j.cyto.2017.08.019 – volume: 136 start-page: 77 year: 2018 ident: 2715_CR5 publication-title: Respir Med doi: 10.1016/j.rmed.2018.02.001 – volume: 194 start-page: 1514 year: 2016 ident: 2715_CR2 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201512-2523OC – volume: 24 start-page: 941 year: 2017 ident: 2715_CR16 publication-title: Acad Radiol doi: 10.1016/j.acra.2016.08.023 – volume: 165 start-page: 378 year: 2002 ident: 2715_CR47 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.165.3.2107134 – volume: 74 start-page: 506 year: 2019 ident: 2715_CR7 publication-title: Thorax doi: 10.1136/thoraxjnl-2018-212446 – volume: 15 start-page: 1 year: 2015 ident: 2715_CR19 publication-title: BMC Pulm Med doi: 10.1186/s12890-015-0124-x – ident: 2715_CR48 doi: 10.1183/13993003.01950-2022 – volume: 197 start-page: 644 year: 2018 ident: 2715_CR28 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201709-1845OC – volume: 307 start-page: e222828 year: 2023 ident: 2715_CR34 publication-title: Radiology doi: 10.1148/radiol.222828 – volume: 8 start-page: 726 year: 2020 ident: 2715_CR1 publication-title: The Lancet Respiratory Medicine doi: 10.1016/S2213-2600(20)30168-5 – volume: 268 start-page: 563 year: 2013 ident: 2715_CR20 publication-title: Radiology doi: 10.1148/radiol.13120816 – ident: 2715_CR22 doi: 10.1111/resp.13820 – ident: 2715_CR18 doi: 10.1183/23120541.00115-2019 – volume: 21 start-page: 2455 year: 2011 ident: 2715_CR27 publication-title: Eur Radiol doi: 10.1007/s00330-011-2223-2 – volume: 368 start-page: 2192 year: 2013 ident: 2715_CR32 publication-title: N Engl J Med doi: 10.1056/NEJMoa1216076 – volume: 9 start-page: 3319 year: 2017 ident: 2715_CR21 publication-title: J Thorac Dis doi: 10.21037/jtd.2017.08.17 – volume: 49 start-page: 843 year: 2019 ident: 2715_CR4 publication-title: Intern Med J doi: 10.1111/imj.14148 – volume: 28 start-page: 26 year: 2010 ident: 2715_CR26 publication-title: Clin Exp Rheumatol |
| SSID | ssj0017875 |
| Score | 2.427343 |
| Snippet | Background
Despite the importance of recognizing interstitial lung abnormalities, screening methods using computer-based quantitative analysis are not well... Despite the importance of recognizing interstitial lung abnormalities, screening methods using computer-based quantitative analysis are not well developed, and... Background Despite the importance of recognizing interstitial lung abnormalities, screening methods using computer-based quantitative analysis are not well... BackgroundDespite the importance of recognizing interstitial lung abnormalities, screening methods using computer-based quantitative analysis are not well... Abstract Background Despite the importance of recognizing interstitial lung abnormalities, screening methods using computer-based quantitative analysis are not... |
| SourceID | doaj unpaywall pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 78 |
| SubjectTerms | Abnormalities Age Analysis Automation Blood Body mass index Body size Care and treatment Chest Computed tomography CT imaging Diagnosis Erythrocyte sedimentation rate Erythrocytes Fibrosis Humans Interstitial lung disease Lung Lung diseases, Interstitial Lungs Male Medical examination Medical imaging Medical screening Medicine Medicine & Public Health Methods Middle Aged Mortality Performance evaluation Pilot projects Pneumology/Respiratory System Prevalence Prognosis Quantitative analysis Reproducibility Retrospective Studies Risk Factors Software Survival analysis Tomography, X-Ray Computed - methods |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals (DOAJ) (NIESG) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQDwUOFW9SCjISEgcaNY4TP7gVRFUhwYlKvVm24wikbXZpN6r67ztjJ-kGUOHAMZmJFXuejiffEPKGQchxwoXclUWdV4HxXAvrcumKhuvWYbsHrLb4Ko5Pqs-n9elGqy-sCUvwwGnhDkLrdMu1bzzzlVRCs1r5oKQCK7WqCeh9C6XHzdRwfgBqWI-_yChxcIFRDbbNZYVnlqzO-SwMRbT-333yRlD6tWByOjW9T-723cpeXdrFYiMwHT0gO0NGSQ_TTB6SO6F7RLa_DGfmj0kXP_phSQCoGl2AcVPrOkxVMQOnA9x3aKi7orajtl8vz-L1z96mSqIoPJown9_T1Tk-gg4B2BsaC7wSuAdF2Ikn5OTo07ePx_nQZSH3got1btsySMlsocvAJOeyCIq3jtehkJCrKJAZ93Wra9-WldPMlyXItWilcNhIXfCnZKtbduE5oRU4_iAc7HkbW2HqxywMoLl3upYshIywcdGNHyDIsRPGwsStiBImCcqAoEwUlOEZeTc9s0oAHLdyf0BZTpwInh1vgEqZQaXM31QqI29REwyaOLyet8OfCjBJBMsyh5BVYX2OZBnZm3GCafo5edQlM7iGC1NqyDIlg-Thj2QOVC44zCkjrycyDozVcF1Y9nEIDnxKwBDPkmZOM-ax9ZSQGVEznZ0tyZzS_fgeccUZ9laodJGR_VG9b97rtjXfn0zgH0S0-z9E9ILcK5M154XYI1vr8z68hOxw7V5FR3ANldVeBw priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1baxQxFA51C14exLujVSIIPtihk2QmmQgirbQUwUXEQt9CkslUYZ3dbneR_nvPyVzaUVl8nDmZkORcMzn5DiGvGbgcJ11IHc-KNA9MpFpalyqXVULXDss9YLbFVB6f5J9Oi9MtMu3vwmBaZW8To6Gu5h7_ke9xDc5ZMbC5HxbnKVaNwtPVvoSG7UorVO8jxNgNss0RGWtCtg8Op1--DucKIJ5Fe9-oSLXmrL9GU8q9C_R8sLXmOZ5rsiIVI1cVEf3_ttvXHNefSZXDyeodcmvdLOzlLzubXXNeR_fI3S7qpPutmNwnW6F5QG5-7s7VH5Im_hjEtAEQRzoDA0CtazCcxSiddpDgoaLuktqG2vVq_jM-n69tm20UGUxbXOh3dLHET9BoQPOKxiSwFgCEIjTFI3JydPjt43HaVWJIvRRyldqaB6WYzTQPTAmhslCK2okiZArimRL4KnxR68LXPHeaec6B91mtpMNi61I8JpNm3oSnhObgHIJ0sC-ubI7hIbPQgRbe6UKxEBLC-kU3voMpx2oZMxO3K6U0LaMMMMpERhmRkLfDN4sWpGNj6wPk5dASAbbji_nyzHT6akLtdC20rzzzuSqlZkXpQ6lKcA62rGCYb1ASDJoBGJ633W0GmCQCapl9iLwwh0exhOyMWoL6-jG5lyXTmY8LcyXs_yQLoAopYE4JeTWQsWPMmGvCfB27ENCulNDFk1YyhxmLWJ5KqoSUI5kdLcmY0vz4HrHHGdZfyHWWkN1evK_GtWnNdwcV-A8WPdu8KM_Jbd7qaZrJHTJZLdfhBcSGK_eyU_jfswFdLQ priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9QwDLdgSHw8IL4pDBQkJB5YRdO0-eBtTEwTEjwxaW9RkqZi0tE7tqvQ_nvstFeuME3weBcnSmI7dmrnZ4DXHE2Olz7mvizqvIpc5EY6nytfNMK0nso9ULbFF3l0XH06qU9GmBx6C7Mdv-davjsne4QX3rKiaCOvc3EdbqCRkikwKw-miAEKXr15FHNpv5nhSfj8f5_CW2bozxTJKU56B2713cpd_HSLxZYpOrwHd0cfku0PTL8P12L3AG5-HqPkD6FLn_koCQCFiy1QnZnzHTmn5HOzEeA7NsxfMNcx16-X39PvH70bcocSu9iA8vyerc6oCx0BSN6wlNI1wHkwApp4BMeHH78eHOVjXYU8SCHXuWvLqBR3hSkjV0KoImrRelHHQqF3opFLItStqUNbVt7wUJbIyaJV0lPpdCkew0637OJTYBUe9VF6vOU2riJnjzscwIjgTa14jBnwzabbMIKOU-2LhU2XDy3twCiLjLKJUVZk8HbqsxogN66k_kC8nCgJLjv9gVJkR-2zsfWmFSY0gYdKaWl4rUPUSuNR73SD03xDkmBJqXF6wY1vE3CRBI9l99GPoowcxTPYnVGiMoZ580aW7HgYnNvSoF-pOLoLlzYLbBVS4JoyeDU108CU_9bFZZ-GEEinJQ7xZJDMacUiFZuSKgM9k9nZlsxbutNvCUmcUzWFyhQZ7G3E-_e8rtrzvUkF_oFFz_5v9Odwuxz0Ni_kLuysz_r4Aj2_tX-ZVP4XaFVNlg priority: 102 providerName: Springer Nature – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdGJ_HxwPdHYCAjIfHA3MVxYse8FcQ0ITHxQKXyZNmOsyFKWroGNP56znGSNWOaQOKtrS-Wfbkv13e_Q-gFBZdjuHHEJHFGUkcZkVwbIkxcMFka3-7BZ1sc8oNp-n6WzbbQtKuFWZ1dMJMW7uZ4vFmJPg-FDr6RglvtLYsy6H3O906864KzcZL6i0maEXYFbfMMQvQR2p4efpx8DpVGGZEy1GOFz2zWFdNcOMnAYTW4_n9a7w33dT61sr9fvYGu1dVSn_7U8_mGC9u_hX50mw-ZK1_H9dqM7a9zuJD_nTu30c026MWTIKV30Jar7qKrH9pr_Xuoav6X9FkLoA14DvYHa1P5aNofEnCLSO4KbE6xrrCu14tvzffvtQ7JTo184QBL_RovV_4Rb7OAvMBNDlrAH8EeGeM-mu6_-_T2gLSNIIjljK-JLhMnBNWxTBwVjInY5aw0LHOxgHAqB7FiNitlZsskNZLaJAHRi0vBje_1ztkDNKoWlXuEcAq-yXEDx_JCpz46pRomkMwamQnqXIRo97aVbVHSfbOOuWpOSzlXgZEKGKkaRioWoVf9M8uAEXIp9RsvRD2lx_duflisjlRrLpQrjSyZtIWlNhU5lzTLrctFDr5J5wUs86UXQeWtECzP6raYAjbp8bzUBAI_n0IkaIR2BpRgPexwuBNi1VqvE5VICIQFhfjmwmEGo4wz2FOEnvfDfmKfsFe5Rd1MwYAu5zDFw6AS_Y5Z0x2LiwjlA2UZsGQ4Un05bqDPqW__kMo4QrudXp2t6zKe7_a69xev6PG_kT9B15OgVyTmO2i0XtXuKYSqa_OsNTy_AVcRios priority: 102 providerName: Unpaywall |
| Title | Interstitial lung abnormality evaluated by an automated quantification system: prevalence and progression rate |
| URI | https://link.springer.com/article/10.1186/s12931-024-02715-3 https://www.ncbi.nlm.nih.gov/pubmed/38321467 https://www.proquest.com/docview/2925671413 https://www.proquest.com/docview/3256363024 https://www.proquest.com/docview/2923325863 https://pubmed.ncbi.nlm.nih.gov/PMC10848490 https://respiratory-research.biomedcentral.com/counter/pdf/10.1186/s12931-024-02715-3 https://doaj.org/article/efb9f39cdc1c47869158ce878911a8de |
| UnpaywallVersion | publishedVersion |
| Volume | 25 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1465-993X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017875 issn: 1465-993X databaseCode: RBZ dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1465-993X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017875 issn: 1465-993X databaseCode: KQ8 dateStart: 20000101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1465-993X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017875 issn: 1465-993X databaseCode: KQ8 dateStart: 20000601 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1465-993X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017875 issn: 1465-993X databaseCode: DOA dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: Academic Search Ultimate (EBSCOhost) customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1465-993X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017875 issn: 1465-993X databaseCode: ABDBF dateStart: 20000101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1465-993X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017875 issn: 1465-993X databaseCode: DIK dateStart: 20000101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1465-993X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017875 issn: 1465-993X databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVAQN databaseName: PubMed Central (WRLC) customDbUrl: eissn: 1465-993X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017875 issn: 1465-993X databaseCode: RPM dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1465-993X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017875 issn: 1465-993X databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1465-993X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017875 issn: 1465-993X databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Open Access Journals customDbUrl: eissn: 1465-993X dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0017875 issn: 1465-993X databaseCode: M48 dateStart: 20000101 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: HAS SpringerNature Open Access 2022 customDbUrl: eissn: 1465-993X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017875 issn: 1465-993X databaseCode: AAJSJ dateStart: 20000401 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals (WRLC) customDbUrl: eissn: 1465-993X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017875 issn: 1465-993X databaseCode: C6C dateStart: 20000104 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3ri9QwEA_3AB8fxLfVc6kg-MGrNk2bNILI3nHHIdxyiAvrp5CkqQprd29vF93_3pn0cVddDv3YzjQkmd9kJs1khpCXFEyO4cZFJomzKHWURZJrEwkTF0yWBss9YLTFiJ-M04-TbLJF2nJHzQRebNzaYT2p8WL65tf5-gMo_Huv8Dl_e4E2CzbFSYonkjSL2DbZBUslsZTDaXp5qgDgzOrbRlkEdnnSXqLZ2EbPUPl8_n-v2lfM1p8hld256m1yc1XN9fqnnk6vmK7ju-RO43OGwxok98iWq-6TG6fNqfoDUvnfghg0AGAMp6D-oTYVOrPoo4dNQnBXhGYd6irUq-Xsh38-X-k61siLN6yzQr8L5wv8BJcMYC9CHwJWp_8IMTHFQzI-Pvp8eBI1dRgiyxlfRrpMnBBUxzJxVDAmYpez0rDMxQK8mRykymxWysyWSWoktUkCko9LwQ2WWufsEdmpZpV7QsIUTIPjBnbFhU7ROaQaGpDMGpkJ6lxAaDvpyjZJyrFWxlT5zUrOVS0oBYJSXlCKBeR19828TtFxLfcByrLjxPTa_sVs8VU12qpcaWTJpC0stanIuaRZbl0ucjANOi-gm68QCQphCd2zurnLAIPEdFpqCH4XRvAIGpC9Hicor-2TWyypFvsqkeCHCgruxUYyAyrjDMYUkBcdGRvGeLnKzVa-CQZ8OYcmHtfI7EbMfHEqLgKS9zDbm5I-pfr-zWcep1h9IZVxQPZbeF_267o53-9U4B9E9PS_BPqM3EpqtY1ivkd2louVew6O4tIMyLaYiAHZPTganX2Cp0N-OPA_XQZ-XQDKeHQ2_PIbOZ9jvw |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKK1E4IN4sFDASiAONGseJHSNVqIVWW_oQQq3Um2s7DiAt2e12V1X_HL-NGefRLqAVlx4TTyzbM57xZMbzEfKagcmxwvrIJnEWpZ7xSAljI2njgqvSItwDZlsciP5R-vk4O14gv9q7MJhW2erEoKiLocN_5GuJAuMsGejcD6PTCFGjMLraQmiYBlqhWA8lxpqLHbv-4hxcuLP1nU_A7zdJsr11-LEfNSgDkRNcTCJTJl5KZmKVeCY5l7HPeWl55mMJtjqHMXOXlSpzZZJaxVySwLziUgqLQOKCQ783yFLKUwXO39Lm1sGXr10cA7ZDVt9vyiKlEtZe28nF2hlaWnDlkxTjqCyL-IxpDAgCf9uJK4byzyTOLpJ7myxPq5G5ODeDwRVjuX2X3GlOuXSjFst7ZMFX98nN_SaO_4BU4UckpimA-NMBKBxqbIXHZ_QKaFOC3BfUXlBTUTOdDH-G59OpqbObgkDRug71ezoa4yeopIC8oCHprC44QrEUxkNydC08eUQWq2HlnxCagjHywoIfXpgUj6PMQAeKO6syybzvEdYuunZNWXRE5xjo4B7lQteM0sAoHRileY-8674Z1UVB5lJvIi87SizoHV4Mx990ox-0L60quXKFYy6VuVAsy53PZQ7GyOQFDPMtSoJGtQPDc6a5PQGTxAJeegNOepgzJFmPrMxQgrpws82tLOlGXZ3py831z2YOrVxwmFOPvOqasWPM0Kv8cBq64ECXC-jicS2Z3Yx5gMMSskfyGZmdWZLZlurH91DrnCHeQ6riHlltxftyXPPWfLXbAv_BoqfzF-UlWe4f7u_pvZ2D3WfkVlLv2SgWK2RxMp7653AundgXzean5OS69c1vO1SYFw |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSAUOiFchUMBISBxo1DhO_OBWFlblVXGgUm-W7TiAtGSXbVao_54ZJxs2UFVw3B17ZHtmPON4_A0hzxi4HCdcSF2elWkRGE-1sC6VLqu4rh2We8BsiyNxeFy8OylPNl7xx2z39ZVk96YBUZqadn9R1Z2JK7F_il4KjsF5gXeQrEz5ZXKlAO-GNQwmYjLcI4A6luunMuf2G7mjiNr_99684Zz-TJwcbk-vk6urZmHPftrZbMNBTW-SG31kSQ86VbhFLoXmNtn-2N-d3yFN_PiHqQGgcnQGRk6tazBkxUic9rDfoaLujNqG2lU7_x5__1jZLqMoCpF22M8v6WKJXXBjgOYVjYleHcgHRfiJu-R4-ubz5DDtqy2kXnDRprbOg5TMZjoPTHIus6B47XgZMgkxiwLZcV_WuvR1XjjNfJ6DfLNaCocF1QXfIVvNvAn3CS3AAQTh4Oxb2QJDQGaBgebe6VKyEBLC1otufA9FjhUxZiYeSZQwnaAMCMpEQRmekBdDn0UHxHFh61coy6ElgmjHP-bLL6a3SRNqp2uufeWZL6QSmpXKByUVOACrKhjmc9QEg6YOw_O2f7EAk0TQLHMA0RXm6UiWkN1RSzBRPyavdcn0W8SpyTVEm5JBEHEumQOVCw5zSsjTgYyMMSuuCfNVZMGhnRLA4l6nmcOMeSxBJWRC1EhnR0sypjTfvkZ8cYY1FgqdJWRvrd6_x3XRmu8NJvAPInrwf9yfkO1Pr6fmw9uj9w_Jtbwz4TQTu2SrXa7CIwgNW_c4Wv8vvEJYzA |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdGJ_HxwPdHYCAjIfHA3MVxYse8FcQ0ITHxQKXyZNmOsyFKWroGNP56znGSNWOaQOKtrS-Wfbkv13e_Q-gFBZdjuHHEJHFGUkcZkVwbIkxcMFka3-7BZ1sc8oNp-n6WzbbQtKuFWZ1dMJMW7uZ4vFmJPg-FDr6RglvtLYsy6H3O906864KzcZL6i0maEXYFbfMMQvQR2p4efpx8DpVGGZEy1GOFz2zWFdNcOMnAYTW4_n9a7w33dT61sr9fvYGu1dVSn_7U8_mGC9u_hX50mw-ZK1_H9dqM7a9zuJD_nTu30c026MWTIKV30Jar7qKrH9pr_Xuoav6X9FkLoA14DvYHa1P5aNofEnCLSO4KbE6xrrCu14tvzffvtQ7JTo184QBL_RovV_4Rb7OAvMBNDlrAH8EeGeM-mu6_-_T2gLSNIIjljK-JLhMnBNWxTBwVjInY5aw0LHOxgHAqB7FiNitlZsskNZLaJAHRi0vBje_1ztkDNKoWlXuEcAq-yXEDx_JCpz46pRomkMwamQnqXIRo97aVbVHSfbOOuWpOSzlXgZEKGKkaRioWoVf9M8uAEXIp9RsvRD2lx_duflisjlRrLpQrjSyZtIWlNhU5lzTLrctFDr5J5wUs86UXQeWtECzP6raYAjbp8bzUBAI_n0IkaIR2BpRgPexwuBNi1VqvE5VICIQFhfjmwmEGo4wz2FOEnvfDfmKfsFe5Rd1MwYAu5zDFw6AS_Y5Z0x2LiwjlA2UZsGQ4Un05bqDPqW__kMo4QrudXp2t6zKe7_a69xev6PG_kT9B15OgVyTmO2i0XtXuKYSqa_OsNTy_AVcRios |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interstitial+lung+abnormality+evaluated+by+an+automated+quantification+system%3A+prevalence+and+progression+rate&rft.jtitle=Respiratory+research&rft.au=Oh%2C+Ju+Hyun&rft.au=Kim%2C+Grace+Hyun+J.&rft.au=Song%2C+Jin+Woo&rft.date=2024-02-06&rft.issn=1465-993X&rft.eissn=1465-993X&rft.volume=25&rft.issue=1&rft_id=info:doi/10.1186%2Fs12931-024-02715-3&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12931_024_02715_3 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-993X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-993X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-993X&client=summon |